¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"lymphokine production"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lymphokine
    ¸²Æ÷Ä«ÀÎ
  • lymphokine-activated killer cell
    ¸²Æ÷Ä«ÀÎȰ¼º»ìÇØ¼¼Æ÷
  • production rate
    »ý»êÀ²
  • production rule
    »êÃâ¿øÄ¢
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lymphokine-activated killer cell
    ¸²Æ÷Ä«ÀÎȰ¼º¼¼Æ÷µ¶¼º¼¼Æ÷
  • lymphokine
    ¸²Æ÷Ä«ÀÎ
  • production rate
    »ý»êÀ²
  • production rule
    »êÃâ¿øÄ¢
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antibody production
    Ç×ü»ý»ê(¡­ßæß§).
  • antibody synthesis =a. production
    Ç×ü»ý»ê, Ç×üÇÕ¼º.
  • aqueous production
    ¹æ¼ö»ý»ê
  • h2o2 production
    °ú»êÈ­¼ö¼Ò»ý»ê
  • heat production
    ¿­»ý»ê(æðßæß§).
  • immunoglobulin production
    ¸é¿ª±Û·ÎºÒ¸°»ý¼º<--»ý»ê>
  • indole production test
    Àε¹»ý»ê½ÃÇè
  • instructive theory of antibody production
    Áö·É¼³ (Ç×ü»ý»ê)
  • production
    »ý»ê
  • production rate
    »ý»êÀ²
  • production rule
    »êÃâ¿øÄ¢<--¹ýÄ¢>
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lymphokine production
    ¸²Æ÷Ų»ý»ê
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lymphokine
    ¸²Æ÷Ų.
  • lymphokine
    ¸²Æ÷Ų.
  • lymphokine activated killer (LAK) cell
    ¸²Æ÷Ä«ÀÎȰ¼º »ìÇØ¼¼Æ÷
  • lymphokine reaction
    ¸²Æ÷Ų¹ÝÀÀ
  • lymphokine-activatcd killer cell
    ¸²Æ÷ŲȰ¼ºÈ­ »ì¼¼Æ÷
  • lymphokine-activated killer cell
    ¸²Æ÷Ų-Ȱ¼º »ì¼¼Æ÷
  • antibody production
    Ç×ü»ý»ê(¡­ßæß§).
  • antibody synthesis =a. production
    Ç×ü»ý»ê, Ç×üÇÕ¼º.
  • aqueous production
    ¹æ¼ö»ý»ê
  • basal heat production
    ±âÃÊ¿­¹ß»ý
  • eosinophil production
    È£»ê±¸»ý¼º
  • erythrocytic production
    ÀûÇ÷±¸»ý»ê.
  • h2o2 production
    °ú»êÈ­¼ö¼Ò»ý»ê
  • heat production
    ¿­»ý»ê(æðßæß§).
  • hormone, ectopic production of
    È£¸£¸ó, À̼Ҽº»ý¼º
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lymphokine
    ¸²Æ÷Ä«ÀÎ
  • production strain
    »ý¼º ÁÖ(ßæà÷ñ»)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
LAK T cells Lymphokine Activated Killer T cells
A-LAK adherent lymphokine-activated killer [cell]
LAK lymphokine-activated killer [cells]
LK left kidney; lichenoid keratosis; lymphokine
GnRH Gonadotropin Releasing Hormone  [HP 1898, 2034]
  = LHRH
  = Go...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ALAK Adherent lymphokine activated killer
LK Lymphokine
LAK Lymphokine (IL-2)-activated-killer
LAK Lymphokine Activated Killer
LAK Lymphokine Activated Killing
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • lymphokine
    ¸²Æ÷Ä«ÀÎ, ¸²Æ÷Ų
    1. Ç׿ø¿¡ ÀÇÇØ Ȱ¼ºÈ­µÈ ¸²ÇÁ±¸°¡ ¹æÃâÇÏ´Â °¡¿ë¼º ´Ü¹é Àü´Þ ¹°ÁúÀÇ ÃÑĪ. 2. Ç׿ø°ú Á¢ÃËÇÏ¿© °¨ÀÛµÈ Àӯı¸¿¡ ÀÇÇØ ºÐºñµÇ´Â ¹°¿¡ ³ì´Â ´Ü¹éÁú Áß°³ÀÚ¸¦ ºÎ¸£´Â °ÍÀÌ´Ù. ´ë½Ä ¼¼Æ÷¸¦ Ȱ¼ºÈ­½Ã۰í Àӯı¸¸¦ º¯Çü½ÃŰ°í ¼¼Æ÷¼º ¸é¿ª¿¡ °ü¿©ÇÑ´Ù.
  • aerosol production
    ºÐ¹« »ý¼º
  • aqueous production
    ¹æ¼ö »ý»ê
  • heat production
    ¿­ »ý»ê
  • megakaryocyte production
    °ÅÇÙ ¼¼Æ÷ »ý»ê
  • paired production
    ÇÙÀÇ
  • production
    »ý¼º, Çü¼º
    ¾î¶² °ÍÀ» »ý»êÇÏ´Â Çൿ ¶Ç´Â °úÁ¤. ¾î¶² °á°ú¸¦ ³º°Å³ª ¾î¶² °ÍÀ» Á¦ÀÛÇÏ´Â °Í.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
killer cells, lymphokine-activated Cytolytic lymphocytes with the unique capacity of killing natural killer (nk)-resistant fresh tumour cells. They are interleukin-2-activated nk cells that have no MHC (major histocompatibility complex) restriction or need for antigen stimulation. Lak cells are used for adoptive immunotherapy in cancer patients.
(12 Dec 1998)
lymphokine <growth factor> Substance produced by a leucocyte that acts upon another cell.
Examples are interleukins, interferon alpha, lymphotoxin (tumour necrosis factor alpha), granulocyte monocyte colony-stimulating factor (GM-CSF). The term is becoming less common and cytokine, a more general term, is taking over. Cytokines include lymphokines.
(20 Mar 1998)
pair production <physics> The simultaneous production of an electron and a positron by an interaction of a photon or a fast charged particle with the electronic field of a nucleus or other particle.
(16 Dec 1997)
primary production Production of organic substances by photosynthesis, the quantity of material so produced per unit time.
(09 Oct 1997)
production The act or process of producing, bringing forth or making.
(18 Nov 1997)
speech production measurement Measurement of parameters of the speech product such as vocal tone, loudness, pitch, voice quality, articulation, resonance, phonation, phonetic structure and prosody.
(12 Dec 1998)
steroid production rate The total quantity of a given steroid formed in the body, usually expressed as milligrams per day; represents the sum of the glandular secretion of the steroid and extraglandular formation of it from various steroid precursors.
(05 Mar 2000)
implantation theory of the production of endometriosis That, at the time of menstruation, cells of the uterine mucosa pass through the fallopian tubes and escape into the pelvic cavity where they implant themselves on the peritoneum.
(05 Mar 2000)
orphan drug production Production of drugs or biologicals which are unlikely to be manufactured by private industry unless special incentives are provided by others.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lymphokine
    ¸²Æ÷Ä«ÀÎ(T¼¼Æ÷°¡ ºÐºñÇÏ´Â È­ÇÐ ¹°Áú)
  • production
    »ý»ê,Á¦ÀÛ,¿¬Ãâ
  • mass production
    ´ë·® »ý»ê 6
  • pair production
    (ÀüÀÚ)½Ö½ß¼º
  • primary production
    1Â÷ »ý»ê(±¤ÇÕ¼º »ý¹°¿¡ ÀÇÇÑ À¯±â¹°ÀÇ »ý»ê)
  • production
    »ý»ê;Á¦ÀÛ;ÀÛǰ;¿¬Ãâ;Á¦ÀÛ¼Ò
  • production concept
    »ý»ê °³³ä(»ý»ê,À¯Åë È¿À²ÀÇ °³¼±À» À§ÇÑ °æ¿µ Áöħ)
  • production control
    »ý»ê °ü¸®
  • production goods
    =PRODUCER(S') GOODS
  • production line
    (Àϰü ÀÛ¾÷ µîÀÇ) °øÁ¤¼±
  • production number
    (¹ÂÁöÄÃÄڹ̵ð µî¿¡¼­) ¹è¿ª ÃÑÃ⿬ÀÇ ³ë·¡(Ãã)
  • production quota
    »ý»ê(·®) ÇÒ´ç
  • production reactor
    »ý»ê¿ë ¿øÀÚ·Î
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á